Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management

Gilead and Kite an­nounced Tues­day it re­ceived FDA ap­proval to short­en its man­u­fac­tur­ing process for the cell ther­a­py Yescar­ta, a move ex­pect­ed to re­duce the

Eligible heart failure patients with a wide QRS complex spent more time alive after use of a cardiac resynchronization therapy defibrillator (CRT-D) compared with an